Dysfunction of the human memory systems: role of the dopaminergic transmission
- PMID: 15129845
- DOI: 10.1097/00019052-200312002-00003
Dysfunction of the human memory systems: role of the dopaminergic transmission
Abstract
Human memory is currently considered to consist of different subsystems subserved by different anatomofunctional networks. However, the biochemical basis of memory disturbances remains unclear. The present review focuses on data from studies in Parkinson's disease in order to define the role played by the dopaminergic system in episodic memory and procedural learning. The pattern of episodic memory disturbances in Parkinson's disease is very specific: Parkinson's disease patients display a preserved ability to encode, store and consolidate new information but have difficulties in retrieving it. This deficit is particularly observed when patients have to self-initiate remembering strategies, as they are unimpaired when retrieval cues are explicitly presented. This probably reflects executive dysfunction, and is related to the disruption of the associative striato-prefrontal circuit. It is observed with verbal as well as visuospatial material. On procedural learning tasks, Parkinson's disease patients display a lower progressive performance enhancement over trials than healthy controls. However, this impairment mainly concerns the initial learning phase and appears to be highly dependent on the motor demands of the task. The role played by dopamine depletion in these deficits remains a subject of debate as some studies suggest the involvement of the dopaminergic system in cognitive function, although other results do not support it. Other neurotransmission systems are probably involved in the pathophysiology of cognitive dysfunction in Parkinson's disease, and currently it is the cholinergic hypothesis that is the most considered.
Similar articles
-
Dopaminergic modulation of cortical function in patients with Parkinson's disease.Ann Neurol. 2002 Feb;51(2):156-64. doi: 10.1002/ana.10078. Ann Neurol. 2002. PMID: 11835371
-
Effects of levodopa on corticostriatal circuits supporting working memory in Parkinson's disease.Cortex. 2017 Aug;93:193-205. doi: 10.1016/j.cortex.2017.05.021. Epub 2017 Jun 7. Cortex. 2017. PMID: 28675834
-
Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease.Drugs Aging. 2000 May;16(5):365-79. doi: 10.2165/00002512-200016050-00006. Drugs Aging. 2000. PMID: 10917074 Review.
-
Memory and executive function in sporadic and familial Parkinson's disease.Brain. 2001 Feb;124(Pt 2):389-98. doi: 10.1093/brain/124.2.389. Brain. 2001. PMID: 11157566 Clinical Trial.
-
[The neuropsychology of nigrostriatal dopaminergic transmission in Parkinson's disease].Fortschr Neurol Psychiatr. 2011 Dec;79(12):692-5. doi: 10.1055/s-0031-1281596. Epub 2011 Oct 18. Fortschr Neurol Psychiatr. 2011. PMID: 22009273 Review. German.
Cited by
-
Treadmill exercise alleviates short-term memory impairment in 6-hydroxydopamine-induced Parkinson's rats.J Exerc Rehabil. 2013 Jun 30;9(3):354-61. doi: 10.12965/jer.130048. eCollection 2013. J Exerc Rehabil. 2013. PMID: 24278884 Free PMC article.
-
Dopamine D2 receptor signaling on iMSNs is required for initiation and vigor of learned actions.Neuropsychopharmacology. 2020 Nov;45(12):2087-2097. doi: 10.1038/s41386-020-00799-1. Epub 2020 Aug 18. Neuropsychopharmacology. 2020. PMID: 32811899 Free PMC article.
-
Lesion to the nigrostriatal dopamine system disrupts stimulus-response habit formation.J Neurosci. 2005 Mar 16;25(11):2771-80. doi: 10.1523/JNEUROSCI.3894-04.2005. J Neurosci. 2005. PMID: 15772337 Free PMC article.
-
Brain catechol-O-methyltransferase (COMT) inhibition by tolcapone counteracts recognition memory deficits in normal and chronic phencyclidine-treated rats and in COMT-Val transgenic mice.Behav Pharmacol. 2016 Aug;27(5):415-21. doi: 10.1097/FBP.0000000000000208. Behav Pharmacol. 2016. PMID: 26919286 Free PMC article.
-
Prospective memory functioning: a new area of investigation in the clinical neuropsychology and rehabilitation of Parkinson's disease and mild cognitive impairment. Review of evidence.Neurol Sci. 2012 Oct;33(5):965-72. doi: 10.1007/s10072-012-0935-y. Epub 2012 Jan 20. Neurol Sci. 2012. PMID: 22262314 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical